LALPATHLAB logo

DR. LAL PATH LABS LTD.

LALPATHLAB·NSE·
1,900.70 -33.90 (-1.75%)
Market Cap31896.97 Cr
PE Ratio63.08
Volume4,17,531
Day High - Low1938.90 - 1873.80
52W High-Low3540.00 - 1272.60
DocStoX Score
5.5/10
Fair
Fair Value
Sign in to see
ROE
22.50%
Strong
P/E
63.08x
Expensive
Debt / Equity
0.08
Low
Industry
Healthcare
Healthcare Service Provider
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day1874
1939
52W1273
3540
DocStoX take

Supported by risk (9.3) and quality (8.8), but held back by valuation (0.0). Risk looks strong at 9.3, but that is offset by valuation at 0.0 and momentum at 1.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.5
/10
Fair
Quality
Excellent
ROE 22.5%
Valuation
Expensive
P/E 63.1×
Growth
Steady
Revenue +11.8% 5Y CAGR
Risk
Low risk
D/E 0.08
Momentum
Weak
28% of 52-week range

At a glance

Market Cap
₹31,897 Cr
52W High / Low
₹3540 / ₹1273
Dividend Yield
0.26%
Promoter Holding
53.19%
EPS (TTM)
₹30.13
Book Value
₹150.00

Key highlights

  • Low leverage — D/E 0.08
  • Capital works hard — ROCE 28%
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Momentum is weak (1.8/10)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

DR. LAL PATH LABS LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.